NCT07501494 Evaluation of Quality Indicators in Patients Receiving Intensive Care and Their Influence on Outcome Indicators and Economic Indicators
| NCT ID | NCT07501494 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Quality Indicators |
| Study Type | OBSERVATIONAL |
| Enrollment | 35,000 participants |
| Start Date | 2026-03-05 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 35,000 participants in total. It began in 2026-03-05 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to identify and evaluate incentive mechanisms for the implementation of quality-relevant care processes. The objective is to correlate adherence to individual process-based quality indicators or their combination with outcome data. In addition, cost shares and case revenues are evaluated. Indices are also derived from routine data that may represent additional influencing factors (Charlson Comorbidity Index or secondary diagnoses that increase case severity based on ICD-10 coding and procedures based on the Surgery and procedure codes system).
Eligibility Criteria
Inclusion Criteria: * Patients with complete, electronically documented intensive care treatment data, including vital sign monitor data and laboratory data from the patient documentation system. * Complete, electronically documented treatment data for these patients from the hospital information system (01.01.2012- 31.12.2024). * Data from cost and revenue accounting from the hospital information system, §21 routine data records. * Age ≥ 18 years * Length of stay \> 24 hours * Intensive care units from the Department of Anesthesiology and Intensive Care Medicie (CCM/CVK) of Charité - University Medicine Berlin: 2012- 2024: M101I, MPACU, WAN-S14I,WAN-S8I, WAN-PACU, 9i, WAC21i und W1i (2020-2022). Since the introduction of electronic patient records, some of these intensive care units have had different names (e.g., MAN-101i, MAN-103i, W1i). Exclusion Criteria: -none
Contact & Investigator
Claudia Spies, MD, Prof.
PRINCIPAL INVESTIGATOR
Charite University, Berlin, Germany
Frequently Asked Questions
Who can join the NCT07501494 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Quality Indicators. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07501494 currently recruiting?
Yes, NCT07501494 is actively recruiting participants. Contact the research team at claudia.spies@charite.de for enrollment information.
Where is the NCT07501494 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT07501494 clinical trial?
NCT07501494 is sponsored by Charite University, Berlin, Germany. The principal investigator is Claudia Spies, MD, Prof. at Charite University, Berlin, Germany. The trial plans to enroll 35,000 participants.